Note 7 - Income Taxes (Details Textual) - USD ($) |
12 Months Ended | |||
---|---|---|---|---|
Dec. 31, 2023 |
Dec. 31, 2022 |
|||
Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount | $ 2,124,000 | $ 3,421,000 | ||
Income Tax Expense (Benefit) | [1] | 800 | 800 | |
Liability for Uncertainty in Income Taxes, Current | 335,822 | |||
Internal Revenue Service (IRS) [Member] | ||||
Operating Loss Carryforwards | 13,548,000 | |||
Deferred Tax Assets, Tax Credit Carryforwards, Research | 1,554,000 | |||
Federal and State R and D [Member] | ||||
Operating Loss Carryforwards | 13,578,000 | |||
Deferred Tax Assets, Tax Credit Carryforwards, Research | 125,000 | |||
General and Administrative Expenses [Member] | ||||
Income Tax Expense (Benefit) | $ 800 | $ 800 | ||
|
X | ||||||||||
- Definition Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount recognized for uncertainty in income taxes classified as current. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|